Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Honeywell
HON
$77B
| $32.7M | 0.03% |
196,223
-51,224
| -21% | -$8.37M |
|
202
Bristol-Myers Squibb
BMY
$133B
| $32.7M | 0.03% |
509,326
-7,375
| -1% | -$422K |
|
203
Onto Innovation
ONTO
$12.9B
| $32.6M | 0.03% |
892,207
-34,682
| -4% | -$1.18M |
|
|
JHG
204
DELISTED
Janus Henderson
JHG
| $31.9M | 0.03% |
1,303,507
-45,334
| -3% | -$1.08M |
|
205
Progress Software
PRGS
$1.66B
| $31.7M | 0.03% |
762,970
-105,538
| -12% | -$4.29M |
|
|
CPE
206
DELISTED
Callon Petroleum Company
CPE
| $31.5M | 0.03% |
652,808
+52,424
| +9% | +$2.17M |
|
207
Wintrust Financial
WTFC
$10.8B
| $31.4M | 0.03% |
442,944
-18,804
| -4% | -$1.25M |
|
208
Idacorp
IDA
$8.27B
| $31.3M | 0.03% |
292,636
-27,054
| -8% | -$2.89M |
|
209
Webster Financial
WBS
$12.5B
| $30.2M | 0.03% |
565,040
-20,855
| -4% | -$1M |
|
|
CONE
210
DELISTED
CyrusOne Inc Common Stock
CONE
| $29.3M | 0.03% |
448,194
-84,243
| -16% | -$5.78M |
|
211
Autodesk
ADSK
$49.5B
| $28.6M | 0.03% |
155,878
-193,469
| -55% | -$31.4M |
|
|
CADE
212
DELISTED
Cadence Bank
CADE
| $28.2M | 0.03% |
898,155
-118,745
| -12% | -$3.67M |
|
213
Delek US
DK
$4.16B
| $28M | 0.03% |
835,932
-213,293
| -20% | -$7.69M |
|
214
Glacier Bancorp
GBCI
$6.42B
| $27.9M | 0.03% |
605,982
-63,506
| -9% | -$2.74M |
|
|
MNDT
215
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $27.8M | 0.03% |
1,679,405
-1,074,090
| -39% | -$17.2M |
|
216
Amgen
AMGN
$208B
| $27.7M | 0.03% |
114,766
-52,321
| -31% | -$11.5M |
|
217
Occidental Petroleum
OXY
$56.8B
| $27.5M | 0.03% |
667,603
-207,893
| -24% | -$8.33M |
|
218
ON Semiconductor
ON
$31.8B
| $27.5M | 0.03% |
1,128,198
-102,479
| -8% | -$2.16M |
|
219
iShares Semiconductor ETF
SOXX
$41.7B
| $27.4M | 0.03% |
327,078
-14,340
| -4% | -$1.1M |
|
220
Qualcomm
QCOM
$155B
| $27.1M | 0.03% |
306,792
-139,234
| -31% | -$11.6M |
|
221
Rogers Corp
ROG
$2.21B
| $27M | 0.03% |
216,751
+33,713
| +18% | +$4.56M |
|
222
Biogen
BIIB
$30B
| $26.9M | 0.03% |
90,777
-33,205
| -27% | -$9.21M |
|
|
PACW
223
DELISTED
PacWest Bancorp
PACW
| $26.9M | 0.03% |
702,130
-39,318
| -5% | -$1.48M |
|
|
COR
224
DELISTED
Coresite Realty Corporation
COR
| $26.7M | 0.03% |
238,566
-6,521
| -3% | -$754K |
|
225
IPG Photonics
IPGP
$3.61B
| $26.6M | 0.03% |
183,671
-9,937
| -5% | -$1.38M |
|
Similar funds
Ken Fisher's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
- Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.